U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07378163) titled 'Study on the Preferences for PCI Implantation Devices Among Doctors and Patients' on Jan. 22.
Brief Summary: The contemporary percutaneous treatment of coronary artery disease typically involves initial lesion preparation with balloon angioplasty, followed by the deployment of a drug-eluting stent (DES) to provide an immediate scaffold and reduce the long-term risk of restenosis. However, stent implantation continues to present notable challenges, primarily due to the metallic scaffold left behind. Compared to DES, drug-coated balloons (DCB) provide a direct release of antiproliferative drugs into the vessel wall, preventing coronar...